The University of Pittsburgh Drug Discovery Institute (DDI) is one among three institutes in the country to be awarded a grant to establish a new Tissue Chip Testing Center (TCTC). The grant, led by Dr. Mark Schurdak, Ph.D., associate professor of computational and systems biology at Pitt’s School of Medicine and Director of Operations of the Drug Discovery Institute, was awarded under the National Institutes of Health (NIH) tissue chip initiative.
More